These Stocks Have Tripled This Year
The stock market has made a lot of people rich since 2009, as several major benchmarks have tripled or even quadrupled during the past eight years. Yet for individual stocks, gains can come a lot more quickly, and a few particularly successful stocks have seen gains of that magnitude in less than eight months. In particular, Everi Holdings (NYSE: EVRI), Kemet (NYSE: KEM), and Sangamo Therapeutics (NASDAQ: SGMO) have all tripled since the beginning of 2017, and investors looking at these stocks for the first time want to know if there's still any profit left in them. Below, you'll learn more about these three companies and whether they can keep gaining ground.
Source: Fool.com
Pfizer Inc. Stock
€26.20
-0.150%
The stock is one of the favorites of our community with 31 Buy predictions and 4 Sell predictions.
As a result the target price of 41 € shows a very positive potential of 56.52% compared to the current price of 26.2 € for Pfizer Inc..
